Case Report
Successful Modified Therapy in a Patient with Probable Infection-Associated Hemophagocytic Lymphohistiocytosis
Table 3
Overview of patient with HLH associated with severe sepsis and septic shock.
| Features consistent with severe sepsis and septic shock |
| Systemic inflammatory response syndrome | + | Infection | Unidentifiable | Hypotension requiring vasopressors | + | Acute respiratory distress syndrome requiring mechanical ventilation | − | Acute renal failure requiring dialysis | + | Altered mental status | + | | + (4.1 mmol/L) | | + () | Disseminated intravascular coagulation | − | Other clinical and laboratory features | Anasarca | − | Hepatomegaly | − | Peak AST (IU/L) | 174 | Peak ALT (IU/L) | 192 | Peak LDH (IU/L) | 285 | Peak total bilirubin (mg/dL) | 22.3 | Peak direct bilirubin (mg/dL) | 18.4 | Peak prothrombin time (s) | 26.6 | Nadir hemoglobin (g/dL) | 5.7 (on hospital day 20) | Nadir absolute neutrophil count (cells/mm3) | 1,600 (on hospital day 26) | Other features | Pericardial effusion, pneumonia, acalculus cholecystitis, acute cholangitis, abdominal wall abscess secondary to cholecystostomy tube |
|
|